Tangram Therapeutics
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Tangram Therapeutics is a biotechnology research company based in London, England. It aims to accelerate medicine development by combining computational approaches with RNA interference, seeking to improve the efficiency and quality of candidate therapies. The firm operates within the biotechnology research industry and positions itself at the intersection of computational science and RNAi-based research. In October 2025, the company announced it is developing GalOmic medicines and plans to evolve its computational capabilities into a more autonomous AI system to inform earlier development decisions and reduce risk. The provided information does not specify Tangram Therapeutics' customer base or target market. The company is described as a relatively small organization within the biotech sector.